<VariationArchive VariationID="2503457" VariationName="NM_013275.6(ANKRD11):c.4964_4965del (p.Lys1655fs)" VariationType="Deletion" Accession="VCV002503457" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-19" DateCreated="2023-11-11" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2668638" VariationID="2503457">
      <GeneList>
        <Gene Symbol="ANKRD11" FullName="ankyrin repeat domain containing 11" GeneID="29123" HGNC_ID="HGNC:21316" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89267630" stop="89490561" display_start="89267630" display_stop="89490561" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89334028" stop="89556968" display_start="89334028" display_stop="89556968" Strand="-" />
          </Location>
          <OMIM>611192</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ANKRD11">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ANKRD11">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_013275.6(ANKRD11):c.4964_4965del (p.Lys1655fs)</Name>
      <CanonicalSPDI>NC_000016.10:89281576:TTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="89281577" stop="89281578" display_start="89281577" display_stop="89281578" variantLength="2" positionVCF="89281576" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="89347985" stop="89347986" display_start="89347985" display_stop="89347986" variantLength="2" positionVCF="89347984" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K1655fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.89281578_89281579del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.89281578_89281579del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.89347986_89347987del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.89347986_89347987del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032003.2" sequenceAccession="NG_032003" sequenceVersion="2" change="g.213984_213985del">
            <Expression>NG_032003.2:g.213984_213985del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256182.2" sequenceAccession="NM_001256182" sequenceVersion="2" change="c.4964_4965del">
            <Expression>NM_001256182.2:c.4964_4965del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001243111.1" sequenceAccession="NP_001243111" sequenceVersion="1" change="p.Lys1655fs">
            <Expression>NP_001243111.1:p.Lys1655fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001256183.2" sequenceAccession="NM_001256183" sequenceVersion="2" change="c.4964_4965del">
            <Expression>NM_001256183.2:c.4964_4965del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001243112.1" sequenceAccession="NP_001243112" sequenceVersion="1" change="p.Lys1655fs">
            <Expression>NP_001243112.1:p.Lys1655fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013275.6" sequenceAccession="NM_013275" sequenceVersion="6" change="c.4964_4965del" MANESelect="true">
            <Expression>NM_013275.6:c.4964_4965del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_037407.4" sequenceAccession="NP_037407" sequenceVersion="4" change="p.Lys1655fs">
            <Expression>NP_037407.4:p.Lys1655fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013275.5" sequenceAccession="NM_013275" sequenceVersion="5" change="c.4964_4965delAA">
            <Expression>NM_013275.5:c.4964_4965delAA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_013275.6(ANKRD11):c.4964_4965del (p.Lys1655fs) AND KBG syndrome" Accession="RCV003388943" Version="2">
        <ClassifiedConditionList TraitSetID="7213">
          <ClassifiedCondition DB="MedGen" ID="C0220687">KBG syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-07-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_013275.6(ANKRD11):c.4964_4965del (p.Lys1655fs) AND ANKRD11-related disorder" Accession="RCV003900990" Version="1">
        <ClassifiedConditionList TraitSetID="89040">
          <ClassifiedCondition>ANKRD11-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-21" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-11-11" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="89040" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="69176" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ANKRD11-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">ANKRD11-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="7213" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2507" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">KBG syndrome</ElementValue>
                <XRef ID="KBG+syndrome/3965" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007846" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Short stature, characteristic facies, macrodontia, mental retardation, and skeletal anomalies</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">KBGS</ElementValue>
                <XRef Type="MIM" ID="148050" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">KBG syndrome is typically characterized by macrodontia (especially of the upper central incisors), characteristic facial features (triangular face, brachycephaly, synophrys, widely spaced eyes, broad or bushy eyebrows, prominent ears, prominent nasal bridge, bulbous nose, anteverted nares, long philtrum, and thin vermilion of the upper lip), short stature, developmental delay / intellectual disability, and behavioral issues. Affected individuals may have feeding difficulties (particularly in infancy), skeletal anomalies (brachydactyly, large anterior fontanelle with delayed closure, scoliosis), hearing loss (conductive, mixed, and sensorineural), seizure disorder, and brain malformations. There is significant variability in the clinical findings, even between affected members of the same family.</Attribute>
                <XRef ID="NBK487886" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="82" />
                <XRef ID="82" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29565525</ID>
                <ID Source="BookShelf">NBK487886</ID>
              </Citation>
              <XRef ID="2332" DB="Orphanet" />
              <XRef ID="C0220687" DB="MedGen" />
              <XRef ID="MONDO:0007846" DB="MONDO" />
              <XRef Type="MIM" ID="148050" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7342318" SubmissionDate="2023-05-06" DateLastUpdated="2023-11-11" DateCreated="2023-11-11">
        <ClinVarSubmissionID localKey="chr16:89281577" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003927976" DateUpdated="2023-11-11" DateCreated="2023-11-11" Type="SCV" Version="1" SubmitterName="Medical Genetics Unit, Azienda USL-IRCCS di Reggio Emilia" OrgID="506424" OrganizationCategory="clinic" OrgAbbreviation="SSDGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG/AMP: PVS1,PM2,PP4</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="2" />
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Description>WES</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Description>WES</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">GMRE_KBG23_10</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">GMRE_KBG23_24</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANKRD11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_013275.6:c.4964_4965del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="148050" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GMRE_KBG_2023a</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8797089" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="20352734|ANKRD11-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004709064" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" OrgAbbreviation="PG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The ANKRD11 c.4964_4965delAA variant is predicted to result in a frameshift and premature protein termination (p.Lys1655Argfs*12). This variant has been reported to have arisen de novo in an individual with psychomotor retardation and syndromic gestalt (Patient 70, Vissers et al. 2017. PubMed ID: 28333917). This variant has not been reported in a large population database, indicating this variant is rare. Frameshift variants in ANKRD11 are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANKRD11" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_013275.5:c.4964_4965delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ANKRD11-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7342318" TraitType="Disease" MappingType="XRef" MappingValue="148050" MappingRef="OMIM">
        <MedGen CUI="C0220687" Name="KBG syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8797089" TraitType="Disease" MappingType="Name" MappingValue="ANKRD11-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="ANKRD11-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

